Diverse Imaging Methods May Influence Long-Term Oncologic Outcomes in Oligorecurrent Prostate Cancer Patients Treated with Metastasis-Directed Therapy (the PRECISE-MDT Study).

PET choline metastasis-directed therapy oligorecurrent prostate cancer prostate-specific membrane antigen

Journal

Journal of nuclear medicine : official publication, Society of Nuclear Medicine
ISSN: 1535-5667
Titre abrégé: J Nucl Med
Pays: United States
ID NLM: 0217410

Informations de publication

Date de publication:
21 Jun 2024
Historique:
received: 09 02 2024
accepted: 09 05 2024
medline: 22 6 2024
pubmed: 22 6 2024
entrez: 21 6 2024
Statut: aheadofprint

Résumé

Metastasis-directed therapy (MDT) has been tested in clinical trials as a treatment option for oligorecurrent prostate cancer (PCa). However, there is an ongoing debate regarding the impact of using different imaging techniques interchangeably for defining lesions and guiding MDT within clinical trials.

Identifiants

pubmed: 38906557
pii: jnumed.124.267586
doi: 10.2967/jnumed.124.267586
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2024 by the Society of Nuclear Medicine and Molecular Imaging.

Auteurs

Matteo Bauckneht (M)

Nuclear Medicine, IRCCS Ospedale Policlinico San Martino, Genova, Italy; matteo.bauckneht@unige.it.
Department of Health Sciences, University of Genova, Genova, Italy.

Francesco Lanfranchi (F)

Department of Health Sciences, University of Genova, Genova, Italy.

Domenico Albano (D)

Nuclear Medicine, ASST Spedali Civili di Brescia, Brescia, Italy.
University of Brescia, Brescia, Italy.

Luca Triggiani (L)

University of Brescia, Brescia, Italy.
Radiation Oncology, ASST Spedali Civili di Brescia, Brescia, Italy.

Flavia Linguanti (F)

Nuclear Medicine, Careggi University Hospital, Florence, Italy.
Nuclear Medicine, Ospedale San Donato, Arezzo, Italy.

Luca Urso (L)

Nuclear Medicine, Oncological Medical and Specialist Department, University Hospital of Ferrara, Ferrara, Italy.

Rosario Mazzola (R)

Advanced Radiation Oncology, IRCCS Sacro Cuore Don Calabria Hospital, Cancer Care Center, Negrar, Italy.

Alessio Rizzo (A)

Nuclear Medicine, Candiolo Cancer Institute, FPO-IRCCS, Turin, Italy.

Elisa D'Angelo (E)

Radiation Oncology, University Hospital of Modena, Modena, Italy.

Francesco Dondi (F)

Nuclear Medicine, ASST Spedali Civili di Brescia, Brescia, Italy.
University of Brescia, Brescia, Italy.

Eneida Mataj (E)

University of Brescia, Brescia, Italy.
Radiation Oncology, ASST Spedali Civili di Brescia, Brescia, Italy.

Gloria Pedersoli (G)

University of Brescia, Brescia, Italy.
Radiation Oncology, ASST Spedali Civili di Brescia, Brescia, Italy.

Elisabetta Maria Abenavoli (EM)

Nuclear Medicine, Careggi University Hospital, Florence, Italy.

Luca Vaggelli (L)

Nuclear Medicine, Careggi University Hospital, Florence, Italy.

Beatrice Detti (B)

Radiation Oncology, Careggi University Hospital, Florence, Italy.

Naima Ortolan (N)

Nuclear Medicine, Oncological Medical and Specialist Department, University Hospital of Ferrara, Ferrara, Italy.

Antonio Malorgio (A)

Radiotherapy, University Hospital of Ferrara, Ferrara, Italy.

Alessia Guarneri (A)

Radiation Oncology, Candiolo Cancer Institute, FPO-IRCCS, Turin, Italy.

Federico Garrou (F)

Nuclear Medicine, AOU Città della Salute e della Scienza di Torino, University of Turin, Turin, Italy.

Matilde Fiorini (M)

Advanced Radiation Oncology, IRCCS Sacro Cuore Don Calabria Hospital, Cancer Care Center, Negrar, Italy.

Serena Grimaldi (S)

Nuclear Medicine, AOU Città della Salute e della Scienza di Torino, University of Turin, Turin, Italy.

Pietro Ghedini (P)

Nuclear Medicine, Oncology, and Haematology Department, University Hospital of Modena, Modena, Italy.

Giuseppe Carlo Iorio (GC)

Radiation Oncology, Department of Oncology, University of Turin, Turin, Italy.

Antonella Iudicello (A)

Nuclear Medicine, Oncology, and Haematology Department, University Hospital of Modena, Modena, Italy.

Guido Rovera (G)

Nuclear Medicine, AOU Città della Salute e della Scienza di Torino, University of Turin, Turin, Italy.

Giuseppe Fornarini (G)

Medical Oncology 1, IRCCS Ospedale Policlinico San Martino, Genova, Italy.

Diego Bongiovanni (D)

Radiation Oncology, Department of Oncology, University of Turin, Turin, Italy.

Michela Marcenaro (M)

Radiotherapy, IRCCS Ospedale Policlinico San Martino, Genova, Italy; and.

Filippo Maria Pazienza (FM)

Nuclear Medicine, AOU Città della Salute e della Scienza di Torino, University of Turin, Turin, Italy.

Giorgia Timon (G)

Radiotherapy, IRCCS Ospedale Policlinico San Martino, Genova, Italy; and.

Matteo Salgarello (M)

Nuclear Medicine, IRCCS Ospedale Sacro Cuore Don Calabria, Negrar, Italy.

Manuela Racca (M)

Nuclear Medicine, Candiolo Cancer Institute, FPO-IRCCS, Turin, Italy.

Mirco Bartolomei (M)

Nuclear Medicine, Oncological Medical and Specialist Department, University Hospital of Ferrara, Ferrara, Italy.

Stefano Panareo (S)

Nuclear Medicine, Oncology, and Haematology Department, University Hospital of Modena, Modena, Italy.

Umberto Ricardi (U)

Radiation Oncology, Department of Oncology, University of Turin, Turin, Italy.

Francesco Bertagna (F)

Nuclear Medicine, ASST Spedali Civili di Brescia, Brescia, Italy.
University of Brescia, Brescia, Italy.

Filippo Alongi (F)

University of Brescia, Brescia, Italy.
Advanced Radiation Oncology, IRCCS Sacro Cuore Don Calabria Hospital, Cancer Care Center, Negrar, Italy.

Salvina Barra (S)

Radiotherapy, IRCCS Ospedale Policlinico San Martino, Genova, Italy; and.

Silvia Morbelli (S)

Nuclear Medicine, AOU Città della Salute e della Scienza di Torino, University of Turin, Turin, Italy.

Gianmario Sambuceti (G)

Nuclear Medicine, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
Department of Health Sciences, University of Genova, Genova, Italy.

Liliana Belgioia (L)

Department of Health Sciences, University of Genova, Genova, Italy.
Radiotherapy, IRCCS Ospedale Policlinico San Martino, Genova, Italy; and.

Classifications MeSH